by Site Dev | Oct 26, 2021 | Clinical Trials, Colorectal
Colorectal CancerClinical Trials Contact Us 1) Phase 1B single agent cohort part of Mirati 849-001/USO 19151: Cohort F – A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation CRC with KRAS G12C...
